Published online before print March 10, 2008, doi: 10.1161/CIRCULATIONAHA.107.188525
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;117:1750-1767.)
© 2008 American Heart Association, Inc.
AHA Scientific Statement |
Percutaneous and Minimally Invasive Valve Procedures
A Scientific Statement From the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group
The incidence of valvular heart disease is expected to increase over the next several decades as a large proportion of the US demographic advances into the later decades of life. At the same time, the next several years can be anticipated to bring a broad transition of surgical therapy to minimally invasive (minithoracotomy and small port) access and the more gradual introduction of percutaneous approaches for the correction of valvular heart disease. Broad acceptance of these technologies will require careful and sometimes perplexing comparisons of the outcomes of these new technologies with existing standards of care. The validation of percutaneous techniques, in particular, will require the collaboration of cardiologists and cardiac surgeons in centers with excellent surgical and catheter experience and a commitment to trial participation. For the near term, percutaneous techniques will likely remain investigational and will be limited in use to patients considered to be high risk or to inoperable surgical candidates. Although current-generation devices and techniques require significant modification before widespread clinical use can be adopted, it must be expected that less invasive and even percutaneous valve therapies will likely have a major impact on the management of patients with valvular heart disease over the next several years.
Key Words: AHA Scientific Statements • cardiac surgery • catheters • interventional radiology • surgery • valves • valvuloplasty
This article has been cited by other articles:
 |
|
 |
|
  A. A. Klein, S. T. Webb, S. Tsui, C. Sudarshan, L. Shapiro, and C. Densem Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology Br. J. Anaesth., December 1, 2009; 103(6): 792 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Manasse Cooks and recipes Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 787 - 790. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bleiziffer, H. Ruge, D. Mazzitelli, A. Hutter, A. Opitz, R. Bauernschmitt, and R. Lange Survival after transapical and transfemoral aortic valve implantation: Talking about two different patient populations J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1073 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F Tops, V. Delgado, F. van der Kley, and J. J Bax Percutaneous aortic valve therapy: clinical experience and the role of multi-modality imaging Heart, September 15, 2009; 95(18): 1538 - 1546. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Grebel and J. Schumm Job Matters: Differences in Risk Assessment of Percutaneous Aortic Valve Replacement Between Cardiologists and Cardiac Surgeons Circ Cardiovasc Qual Outcomes, September 1, 2009; 2(5): 465 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Ussia, M. Mule, M. Barbanti, V. Cammalleri, M. Scarabelli, S. Imme, D. Capodanno, S. Ciriminna, and C. Tamburino Quality of life assessment after percutaneous aortic valve implantation Eur. Heart J., July 2, 2009; 30(14): 1790 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bleiziffer, H. Ruge, D. Mazzitelli, C. Schreiber, A. Hutter, J.-C. Laborde, R. Bauernschmitt, and R. Lange Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 615 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Goel, P P Sengupta, F Mookadam, H P Chaliki, B K Khandheria, and A J Tajik Valvular regurgitation and stenosis: when is surgery required? Heart Asia, March 31, 2009; 2009(3): 5 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper CHAPTER 21 Valvular Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zierer, G. Wimmer-Greinecker, S. Martens, A. Moritz, and M. Doss The transapical approach for aortic valve implantation. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 948 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gammie, L. S. Krowsoski, J. M. Brown, P. N. Odonkor, C. A. Young, M. J. Santos, J. S. Gottdiener, and B. P. Griffith Aortic Valve Bypass Surgery: Midterm Clinical Outcomes in a High-Risk Aortic Stenosis Population Circulation, September 30, 2008; 118(14): 1460 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur. Heart J., June 1, 2008; 29(11): 1463 - 1470. [Abstract] [Full Text] [PDF]
|
|